TMEM179B Variant 1: A Protein Target for Cancer and Neurodegenerative Diseases

Target Name: TMEM179B

NCBI ID: G374395

TMEM179B Variant 1: A Protein Target for Cancer and Neurodegenerative Diseases

TMEM179B (Transmembrane protein 179B) is a protein that plays an important role in the cell membrane. TMEM179B is responsible for maintaining cell morphology, transporting substances inside and outside the cell, and cell signaling on the cell membrane. Its functional and structural characteristics make it a very attractive drug target.

The variant of TMEM179B, TMEM179B variant 1, is a protein with mutations. Its mutation leads to changes in the protein structure, which changes the function and activity of TMEM179B variant 1. These changes transform TMEM179B variant 1 from a normal protein into an abnormal, pathologically active protein.

The abnormal activity of TMEM179B variant 1 leads to its accumulation within cells. These abnormal proteins can interfere with normal intracellular material transport and signal transmission processes, leading to cell growth, differentiation and functional disorders. These abnormal proteins may also lead to a series of adverse events in cells, such as cell death, cell cycle abnormalities, and apoptosis.

Because TMEM179B variant 1 is an abnormal, pathologically active protein, it is widely considered as a drug target. Scientists have discovered multiple drug targets related to TMEM179B variant 1 and are studying these targets in depth. These drug targets include intracellular transport systems, cell signaling systems, cell adhesion systems, etc.

In addition, TMEM179B variant 1 is also closely related to the occurrence and development of various diseases. For example, it is closely related to the occurrence and development of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. In addition, TMEM179B variant 1 is also closely related to the occurrence and development of tumors. It is closely related to the occurrence and development of various tumors, such as breast cancer, lung cancer, prostate cancer, etc.

TMEM179B variant 1 is a very attractive drug target with good clinical prospects. Scientists are conducting in-depth studies on the pathological mechanism of TMEM179B variant 1 in order to discover new drug targets.

Protein Name: Transmembrane Protein 179B

More Common Targets